Flowonix Medical said yesterday that it won FDA approval to market the updated software used to program the company’s Prometra infusion system.
The clinician programmer software, which Flowonix plans to launch in February, includes automatic calculations and increased dosing flexibility during bridge bolusing, according to the company.
Get the full story at our sister site, Drug Delivery Business News.
